Stay updated on Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.

Latest updates to the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedRevision updated to v3.4.2 from v3.4.1. This is a minor UI/system update with no impact on study content, eligibility, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedMinor version update from v3.4.0 to v3.4.1 with no visible changes to study content, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a Pan-Asian subgroup publication for EV-302; glossary display is now available, and the page revision updated to v3.4.0.SummaryDifference0.1%

- Check54 days agoChange DetectedMinor revision tag updated from v3.3.3 to v3.3.4 on the page; no user-facing content or study data were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check82 days agoChange DetectedLocations entries were reorganized: per-state location items were removed and replaced with consolidated regional listings, and a new revision tag v3.3.3 was added.SummaryDifference0.8%

Stay in the know with updates to Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.